These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30150195)

  • 1. Effect of haloperidol on behavioral sensitization and cognition in methylphenidate and buspirone-methylphenidate co-administered rats.
    Alam N; Ikram R
    Pak J Pharm Sci; 2018 Sep; 31(5):1959-1965. PubMed ID: 30150195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of methylphenidate-induced sensitization by co-administration of buspirone.
    Alam N; Najam R; Naeem S
    Pak J Pharm Sci; 2016 Mar; 29(2):585-90. PubMed ID: 27087081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol attenuates Methylphenidate and Modafinil induced behavioural sensitization and cognitive enhancement.
    Alam N; Choudhary K
    Metab Brain Dis; 2018 Jun; 33(3):893-906. PubMed ID: 29470766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of methylphenidate-induced tolerance on cognition by buspirone co-administration.
    Alam N; Najam R; Khan SS
    Pak J Pharm Sci; 2015 Sep; 28(5):1601-5. PubMed ID: 26408868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate-induced hepatotoxicity in rats and its reduction by buspirone.
    Alam N; Ikram R
    Pak J Pharm Sci; 2018 May; 31(3):741-745. PubMed ID: 29716850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 5-HT1A receptors in the ability of mixed 5-HT1A receptor agonist/dopamine D2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats.
    Kleven M; Prinssen EP; Koek W
    Eur J Pharmacol; 1996 Oct; 313(1-2):25-34. PubMed ID: 8905325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Methylphenidate and buspirone-methylphenidate co-administration on biochemical and hematological parameters in rats: Implications for safe and confrontational use.
    Alam N; Ikram R; Naeem S; Khan SS; Siddiqui T; Khatoon H; Kashif SS
    Pak J Pharm Sci; 2021 Nov; 34(6):2131-2139. PubMed ID: 35034873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of 5-HT-1A Somatodentritic Receptors in Tryptophan Treated and Co-treated Rats Induced by Methylphenidate.
    Farhan M; Riaz F; Wali S; Rafiq H
    Curr Clin Pharmacol; 2019; 14(2):125-131. PubMed ID: 30417792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of apomorphine-induced sensitization by buspirone.
    Ikram H; Haleem DJ
    Pharmacol Biochem Behav; 2011 Sep; 99(3):444-50. PubMed ID: 21530573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists.
    Meririnne E; Kankaanpää A; Seppälä T
    J Pharmacol Exp Ther; 2001 Aug; 298(2):539-50. PubMed ID: 11454915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated restraint stress potentiates methylphenidate and modafinil-induced behavioral sensitization in rats.
    Alam N; Chaudhary K
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):785-795. PubMed ID: 31853616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of serotonin 5-HT
    Nie L; Di T; Li Y; Cheng P; Li M; Gao J
    Pharmacol Biochem Behav; 2018 Aug; 171():74-84. PubMed ID: 29944910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats.
    Yang PB; Swann AC; Dafny N
    Neuropharmacology; 2006 Sep; 51(3):546-56. PubMed ID: 16824558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum.
    Haleem DJ; Ikram H; Haleem MA
    Brain Res; 2014 Oct; 1586():73-82. PubMed ID: 25160128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent response of central dopaminergic systems to buspirone in mice.
    Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Gursale SC; Balsara JJ
    Indian J Exp Biol; 2008 Oct; 46(10):704-14. PubMed ID: 19024168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.